BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 8053233)

  • 1. [Prognostic factors of metastatic breast cancer--2].
    Brockmann B; Reitzig P; Dietzmann A; Cyganiak P
    Z Arztl Fortbild (Jena); 1994 Apr; 88(4):305-9. PubMed ID: 8053233
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical course of recurrent and metastatic disease in breast cancer].
    Koffmann B; Baez MR
    Rev Med Chil; 1991 Apr; 119(4):423-7. PubMed ID: 1842986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Principles of adjuvant therapy.
    Dawson JW; Taylor I
    Br J Hosp Med; 1995 Sep 20-Oct 3; 54(6):249-54. PubMed ID: 8542172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for local recurrence in patients with invasive breast cancer and negative surgical margins of excision. Where are we and where are we going?
    Schnitt SJ
    Am J Clin Pathol; 2003 Oct; 120(4):485-8. PubMed ID: 14560560
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment guideline for advanced or recurrent breast cancer].
    Watanabe T; Katsumata N; Saijo N
    Nihon Rinsho; 2000 Apr; 58 Suppl():237-45. PubMed ID: 11026001
    [No Abstract]   [Full Text] [Related]  

  • 6. [New after-care guidelines in breast carcinoma].
    Sauer H
    Geburtshilfe Frauenheilkd; 1996 Sep; 56(9):M141-3. PubMed ID: 8991837
    [No Abstract]   [Full Text] [Related]  

  • 7. Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods.
    Skowronek J; Piotrowski T
    Neoplasma; 2002; 49(6):426-31. PubMed ID: 12584593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of the site of recurrence to subsequent breast cancer survival.
    Imkampe A; Bendall S; Bates T
    Eur J Surg Oncol; 2007 May; 33(4):420-3. PubMed ID: 17049430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic analysis of recurrent breast cancer.
    Matsumoto K
    Jpn J Clin Oncol; 1985 Dec; 15(4):595-601. PubMed ID: 4094092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of patients with locally recurrent breast cancer.
    Voogd AC; van Tienhoven G
    Am J Surg; 2007 Jan; 193(1):138. PubMed ID: 17188110
    [No Abstract]   [Full Text] [Related]  

  • 11. [Local recurrence of breast cancer: prognostic factors, effect of adjuvant therapy].
    Castiglione-Gertsch M
    Helv Chir Acta; 1992 May; 59(1):143-6. PubMed ID: 1526820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initially metastatic breast carcinoma has a distinct disease pattern but an equivalent outcome compared with recurrent metastatic breast carcinoma.
    Jimeno A; Amador ML; González-Cortijo L; Tornamira MV; Ropero S; Valentín V; Hornedo J; Cortés-Funes H; Colomer R
    Cancer; 2004 May; 100(9):1833-42. PubMed ID: 15112263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen-dependent prognostic significance of cyclooxygenase-2 expression in early-stage invasive breast cancers treated with breast-conserving surgery and radiation.
    Haffty BG; Yang Q; Moran MS; Tan AR; Reiss M
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1006-13. PubMed ID: 18262731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tumor biology-oriented treatment concepts in gynecologic oncology].
    Graeff H
    Geburtshilfe Frauenheilkd; 1995 Mar; 55(3):M27-31. PubMed ID: 7665053
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
    Lobbezoo DJ; van Kampen RJ; Voogd AC; Dercksen MW; van den Berkmortel F; Smilde TJ; van de Wouw AJ; Peters FP; van Riel JM; Peters NA; de Boer M; Peer PG; Tjan-Heijnen VC
    Br J Cancer; 2015 Apr; 112(9):1445-51. PubMed ID: 25880008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy in stage III breast cancer.
    Alassas M; Chu Q; Burton G; Ampil F; Mizell J; Li BD
    Am Surg; 2005 Jun; 71(6):487-92. PubMed ID: 16044927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late lines of treatment benefit survival in metastatic breast cancer in current practice?
    Planchat E; Abrial C; Thivat E; Mouret-Reynier MA; Kwiatkowski F; Pomel C; Wang-Lopez Q; Chollet P; Nabholtz JM; Durando X
    Breast; 2011 Dec; 20(6):574-8. PubMed ID: 21852136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
    Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics, prognostic value, and therapeutic modalities for local recurrences of breast cancer after conservative treatment].
    Body G; Brémond A; Cappelaere P; Dauplat J; Kurtz J; Suzanne F
    J Gynecol Obstet Biol Reprod (Paris); 1994; 23(3):264-73. PubMed ID: 8051346
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic factors for death after an isolated local recurrence in patients with early-stage breast carcinoma.
    Lê MG; Arriagada R; Spielmann M; Guinebretière JM; Rochard F
    Cancer; 2002 Jun; 94(11):2813-20. PubMed ID: 12115367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.